ÂÜÀòÂÒÂ×

Seth Fischer joined the Esperion Board of Directors in November 2021. With more than 38 years of experience in the pharmaceutical and medical device industry, he brings deep operational and commercial expertise, with a successful track record of developing and executing strategies to drive product growth.

Seth currently serves as a member of the board of directors of Marinus Pharmaceuticals, Inc. and Agile Therapeutics, Inc., and an advisor to MedHab, LLC. Previously, he served as the chief executive officer and as a director of Vivus, Inc., a company commercializing and developing innovative, next-generation therapies to address unmet needs. Prior to Vivus, Seth served over 29 years in various positions of increasing responsibility at Johnson & Johnson. Most recently he was company group chairman, Johnson & Johnson, and worldwide franchise chairman of Cordis Corporation. Before that, he served as company group chairman, North America Pharmaceuticals, which included responsibilities for Ortho-McNeil Pharmaceuticals, Janssen, and Scios.

Seth earned his bachelor’s degree in general studies from Ohio University and served as a captain in the U.S. Air Force.